{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"OtherAbstract": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "SpaceFlightMission": [], "KeywordList": [], "InvestigatorList": [], "PMID": "3905440", "DateCompleted": {"Year": "1986", "Month": "01", "Day": "17"}, "DateRevised": {"Year": "2015", "Month": "11", "Day": "19"}, "Article": {"Language": ["eng"], "ArticleDate": [], "ELocationID": [], "Journal": {"ISSN": "0748-7983", "JournalIssue": {"Volume": "11", "Issue": "4", "PubDate": {"Year": "1985", "Month": "Dec"}}, "Title": "European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology", "ISOAbbreviation": "Eur J Surg Oncol"}, "ArticleTitle": "Controlled trial of RSV, herbs or placebo as adjuvants to complete resection of squamous cell lung cancer.", "Pagination": {"StartPage": "349", "EndPage": "351", "MedlinePgn": "349-51"}, "Abstract": {"AbstractText": ["152 completely resected patients with high or intermediate differentiated squamous cell lung cancer were randomized to receive 6 months adjuvant therapy with RSV (1, 2-diphenyl-alpha beta-diketone) herbs or placebo. No significant differences were observed in duration of survival or relapse rates between the three groups."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [], "LastName": "Osterlind", "ForeName": "K", "Initials": "K"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Hansen", "ForeName": "M", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Hansen", "ForeName": "H H", "Initials": "HH"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Dombernowsky", "ForeName": "P", "Initials": "P"}], "PublicationTypeList": ["Clinical Trial", "Journal Article", "Randomized Controlled Trial", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Eur J Surg Oncol", "NlmUniqueID": "8504356", "ISSNLinking": "0748-7983"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Aldehydes"}, {"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}, {"RegistryNumber": "N45G3015PA", "NameOfSubstance": "Phenylglyoxal"}, {"RegistryNumber": "S85X61172J", "NameOfSubstance": "benzil"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Actuarial Analysis"}, {"QualifierName": [], "DescriptorName": "Adult"}, {"QualifierName": [], "DescriptorName": "Aged"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Aldehydes"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Antineoplastic Agents"}, {"QualifierName": ["drug therapy", "surgery"], "DescriptorName": "Carcinoma, Squamous Cell"}, {"QualifierName": [], "DescriptorName": "Clinical Trials as Topic"}, {"QualifierName": [], "DescriptorName": "Combined Modality Therapy"}, {"QualifierName": [], "DescriptorName": "Denmark"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["drug therapy", "surgery"], "DescriptorName": "Lung Neoplasms"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Middle Aged"}, {"QualifierName": ["analogs & derivatives", "therapeutic use"], "DescriptorName": "Phenylglyoxal"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Plant Extracts"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Random Allocation"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "1985", "Month": "12", "Day": "1"}, {"Year": "1985", "Month": "12", "Day": "1", "Hour": "0", "Minute": "1"}, {"Year": "1985", "Month": "12", "Day": "1", "Hour": "0", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["3905440"]}}]}